SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.19%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$339M
AUM Growth
+$339M
(+59%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
39.85%
Top 10 Holdings %
Top 10 Hldgs %
57.87%
Holding
181
New
46
Increased
26
Reduced
25
Closed
28
Top Buys
| 1 |
Weyerhaeuser
WY
|
$64.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$34M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$8.75M |
| 4 |
AGN
Allergan plc
AGN
|
$7.45M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$5.83M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$11M |
| 2 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$8.78M |
| 3 |
Sarepta Therapeutics
SRPT
|
$6.71M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$6.23M |
| 5 |
Thermo Fisher Scientific
TMO
|
$4.65M |
Sector Composition
| 1 | Healthcare | 64.94% |
| 2 | Real Estate | 19.41% |
| 3 | Energy | 2.49% |
| 4 | Consumer Discretionary | 1.61% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXGN
26
DELISTED
OXIGENE INC COM
OXGN
| $2.88M | 0.12% |
+1,111,798
| New | +$2.88M |
|
|
RIBT
27
DELISTED
RiceBran Technologies
RIBT
| $2.86M | 0.12% |
+541,044
| New | +$2.86M |
|
28
Tonix Pharmaceuticals
TNXP
$241M
| $2.7M | 0.12% |
187,894
-87,106
| -32% | -$1.25M |
|
29
Lipocine
LPCN
$15.6M
| $2.54M | 0.11% |
+416,700
| New | +$2.54M |
|
30
Arrowhead Research
ARWR
$3.83B
| $2.47M | 0.11% |
+172,353
| New | +$2.47M |
|
|
AVNR
31
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $2.45M | 0.11% |
+434,000
| New | +$2.45M |
|
32
Xencor
XNCR
$591M
| $2.44M | 0.1% |
+209,686
| New | +$2.44M |
|
|
RVNC
33
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.29M | 0.1% |
+67,200
| New | +$2.29M |
|
34
Vanda Pharmaceuticals
VNDA
$278M
| $2.1M | 0.09% |
+130,000
| New | +$2.1M |
|
35
Novavax
NVAX
$1.21B
| $1.93M | 0.08% |
418,378
+166,878
| +66% | +$771K |
|
36
Carisma Therapeutics
CARM
$14.8M
| $1.9M | 0.08% |
+143,974
| New | +$1.9M |
|
|
ACGN
37
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $1.79M | 0.08% |
616,600
+601,600
| +4,011% | +$1.74M |
|
38
MEI Pharma
MEIP
$149M
| $1.71M | 0.07% |
+270,000
| New | +$1.71M |
|
39
Heron Therapeutics
HRTX
$199M
| $1.67M | 0.07% |
+135,281
| New | +$1.67M |
|
40
Tempest Therapeutics
TPST
$46M
| $1.66M | 0.07% |
180,690
-176,664
| -49% | -$1.62M |
|
|
CEMP
41
DELISTED
Cempra, Inc.
CEMP
| $1.6M | 0.07% |
149,000
-256,946
| -63% | -$2.76M |
|
|
PGNX
42
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.57M | 0.07% |
365,186
-152,608
| -29% | -$658K |
|
|
ANTH
43
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.52M | 0.07% |
448,000
-240,037
| -35% | -$814K |
|
|
EPZM
44
DELISTED
Epizyme, Inc
EPZM
| $1.52M | 0.07% |
48,790
-102,430
| -68% | -$3.19M |
|
|
SCTL
45
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.5M | 0.06% |
186,940
-40,853
| -18% | -$327K |
|
46
Bristol-Myers Squibb
BMY
$96.7B
| $1.45M | 0.06% |
+29,949
| New | +$1.45M |
|
47
Semler Scientific
SMLR
$425M
| $1.38M | 0.06% |
334,038
+15,840
| +5% | +$65.4K |
|
48
Xoma
XOMA
$423M
| $1.3M | 0.06% |
282,594
+117,866
| +72% | +$541K |
|
|
CBST
49
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $1.26M | 0.05% |
18,086
+1,496
| +9% | +$104K |
|
|
LUMO
50
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.22M | 0.05% |
+46,098
| New | +$1.22M |
|